JPH09285522A - Chemical vessel - Google Patents
Chemical vesselInfo
- Publication number
- JPH09285522A JPH09285522A JP8122657A JP12265796A JPH09285522A JP H09285522 A JPH09285522 A JP H09285522A JP 8122657 A JP8122657 A JP 8122657A JP 12265796 A JP12265796 A JP 12265796A JP H09285522 A JPH09285522 A JP H09285522A
- Authority
- JP
- Japan
- Prior art keywords
- pierced
- protective film
- container
- rubber stopper
- needle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Closures For Containers (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、容器に薬剤が収納さ
れ、上記容器の開口部はゴム栓で密封され、上記容器の
外部から容器内部に通ずる連通路を確保するために連通
針をゴム栓に刺通して用いる薬剤容器であって、少なく
とも上記ゴム栓の被刺通面が上記連通針で刺通可能な保
護膜で覆われており、上記保護膜の表面が滅菌処理され
ている薬剤容器に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a container in which a medicine is contained, an opening of the container is sealed with a rubber stopper, and a communication needle is provided with a rubber to secure a communication passage from the outside of the container to the inside of the container. A drug container used by piercing a stopper, wherein at least the pierced surface of the rubber stopper is covered with a protective film piercable by the communication needle, and the surface of the protective film is sterilized. It is about.
【0002】[0002]
【従来の技術】一般に薬剤容器は抗生物質や抗ガン剤の
ような粉末薬剤或いは凍結乾燥剤が収納され、開口部が
ゴム栓で密栓されたバイアルなどからなる。一方、点滴
注射に用いられる輸液等のバック、コンテナ等の医療用
容器は、フレキシブルな壁を有した非定型性で、溶出物
等がでない可撓性容器である。このような可撓性容器は
連結口を備え、上述のバイアル等の薬剤容器が連結口を
介して接続される。可撓性容器内と薬剤容器内との連通
には一般に連結口に配された連通針によって行われる。
例えば、連結口には一般に、連通手段として金属或いは
樹脂製の連通針が設けられ、可撓性容器内と連通されて
いる連通針が薬剤容器のゴム栓に刺通して連通されるも
のがある。2. Description of the Related Art In general, a medicine container contains a powder medicine such as an antibiotic or an anticancer agent or a lyophilized agent, and is formed of a vial whose opening is sealed with a rubber stopper. On the other hand, medical containers such as bags and containers for infusions and the like used for intravenous injections are flexible containers having a flexible wall and having no eluate or the like. Such a flexible container has a connection port, and the medicine container such as the above-mentioned vial is connected through the connection port. Communication between the flexible container and the medicine container is generally performed by a communication needle arranged at the connection port.
For example, in general, a communication needle made of metal or resin is provided at the connection port as communication means, and a communication needle communicating with the inside of the flexible container is pierced into a rubber stopper of the medicine container to communicate therewith.
【0003】[0003]
【発明が解決しようとする課題】ところで、抗生物質や
抗ガン剤のような粉末薬剤或いは凍結乾燥剤が封入され
ている従来の薬剤入り容器は、容器の開口部を密封して
いるゴム栓が容器のガラス部分に比較して水蒸気や気体
を透過し易く、その水分や気体によって薬剤が変質する
ので、薬剤封入後において、連通針を挿入するゴム栓表
面をEOG滅菌や過酸化水素水により化学滅菌ができな
かった。このため、薬剤入り容器のゴム栓の少なくとも
一部を保護膜にて覆うことによりEOG滅菌や過酸化水
素水による滅菌を可能にした。即ち、ゴム栓の表面を保
護膜で覆い、被刺通面を覆う保護膜は連通針の刺通が可
能となっている。この保護膜の表面にEOG滅菌や過酸
化水素水を接触させることにより、保護膜表面は滅菌若
しくは殺菌される。そして、保護膜はゴム材質と比較し
て気体や液体の透過が極端に少なく且つ変質がないの
で、ゴム材質や容器内の薬剤に対して影響を与えない。
また、保護膜に高周波誘導等により磁力線を加えて渦電
流を発生させ、保護膜だけを加熱して保護膜表面を加熱
殺菌することも可能である。また、保護膜は電子線から
のゴム栓表面を保護しその劣化をも防止する。A conventional drug-containing container enclosing a powdered drug such as an antibiotic or an anticancer drug or a lyophilized agent has a rubber stopper that seals the opening of the container. Water vapor and gas are easier to permeate than the glass part of the container, and the drug is degraded by the water or gas. Sterilization failed. For this reason, EOG sterilization and sterilization with a hydrogen peroxide solution are made possible by covering at least a part of the rubber stopper of the container containing the medicine with a protective film. That is, the surface of the rubber stopper is covered with a protective film, and the protective film covering the pierced surface allows the communication needle to penetrate. By contacting the surface of this protective film with EOG sterilization or hydrogen peroxide solution, the surface of the protective film is sterilized or sterilized. Further, the protective film has extremely little gas and liquid permeation as compared with the rubber material and does not deteriorate, so that the protective film does not affect the rubber material or the medicine in the container.
In addition, it is also possible to generate an eddy current by applying magnetic lines of force to the protective film by high frequency induction or the like, and heat only the protective film to sterilize the surface of the protective film by heating. In addition, the protective film protects the surface of the rubber stopper from the electron beam and prevents its deterioration.
【0004】しかしながら、かかる保護膜によるゴム栓
の保護は、以下の点に問題が見られる。金属は展性があ
り、その膜或いは箔に連通針が刺通されると、その連通
針の側壁の摺接により、接触部分の膜或いは箔は展性に
より延び、次に刺通するゴム栓の穿刺穴内にまで引きず
られる。このため、金属片が薬剤容器内に通り込まれて
薬剤を汚染するおそれがある。このような現象は薄肉に
展性形成したアルミ箔或いはステンレス膜などの部分に
見られる。従って、本発明は、可撓性容器を無菌的に連
結する場合、連結直前にゴム栓の表面を安全且つ確実に
滅菌若しくは殺菌することができ、また連通針の刺通時
に薬剤等の汚染が生じない薬剤容器を提供することにあ
る。However, the protection of the rubber stopper by such a protective film has the following problems. The metal is malleable, and when the communicating needle is pierced through the membrane or foil, the film or foil at the contact portion extends by malleability due to the sliding contact of the side wall of the communicating needle, and then the rubber plug is pierced. Dragged into the puncture hole. For this reason, there is a possibility that the metal piece may pass through the medicine container and contaminate the medicine. Such a phenomenon is observed in a portion such as an aluminum foil or a stainless film which is formed to be thin and malleable. Therefore, according to the present invention, when the flexible containers are aseptically connected, the surface of the rubber stopper can be sterilized or sterilized safely and reliably immediately before the connection, and the contamination of the medicine or the like at the time of the insertion of the communication needle can be achieved. It is to provide a drug container that does not occur.
【0005】[0005]
【課題を解決するための手段】本発明は、容器に薬剤が
収納され、上記容器の開口部はゴム栓で密封され、上記
容器の外部から容器内部に通ずる連通路を確保するため
に連通針をゴム栓に刺通して用いる薬剤容器であって、
少なくとも上記ゴム栓の被刺通面が上記連通針で刺通可
能な保護膜で覆われており、上記保護膜の表面が滅菌処
理されている薬剤容器において、上記ゴム栓の被刺通面
と上記保護膜とが連通針の刺通時点で0.7mm以上離
間していることを特徴とする薬剤容器を提供することに
より、上記目的を達成したものである。SUMMARY OF THE INVENTION According to the present invention, a medicine is stored in a container, an opening of the container is sealed with a rubber stopper, and a communication needle is provided to secure a communication path from the outside of the container to the inside of the container. Is a drug container used by piercing a rubber stopper,
At least the pierced surface of the rubber stopper is covered with a protective film that can be pierced with the communication needle, and the surface of the protective film is sterilized in a drug container. The object has been achieved by providing a medicine container characterized in that the medicine container is separated from the protective film by 0.7 mm or more at the time of piercing of the communication needle.
【0006】本発明に係る薬剤容器において、上記保護
膜は上記被刺通面から浮き上がらせて配されているもの
である。本発明に係る薬剤容器において、上記ゴム栓の
表面には穴部が形成され、該穴の底面を上記被刺通面と
するものである。本発明に係る薬剤容器において、上記
保護膜はアルミニウム或いはステンレス金属からなり、
上記被刺通面を覆う部分を除いて肉厚に形成され、且つ
上記ゴム栓を上記開口部に固定するためのカシメキャッ
プの一部であるものである。本発明に係る薬剤容器にお
いて、上記滅菌処理が化学滅菌処理である。本発明に係
る薬剤容器において、連通針を具備した可撓性容器に連
結されており、上記ゴム栓の被刺通面と上記保護膜とが
上記連通針の外径Lの1/2以上離間していることを特
徴とする。In the medicine container according to the present invention, the protective film is provided so as to float from the piercing surface. In the drug container according to the present invention, a hole is formed on the surface of the rubber stopper, and the bottom surface of the hole serves as the pierced surface. In the drug container according to the present invention, the protective film is made of aluminum or stainless metal,
The rubber cap is formed thick except for a portion covering the pierced surface, and is a part of a caulking cap for fixing the rubber stopper to the opening. In the drug container according to the present invention, the sterilization treatment is a chemical sterilization treatment. In the medicine container according to the present invention, the medicine container is connected to a flexible container having a communication needle, and the pierced surface of the rubber stopper is separated from the protective film by 以上 or more of the outer diameter L of the communication needle. It is characterized by doing.
【0007】[0007]
【作用】上記薬剤容器はその内部が連通針によって可撓
性容器内と連通され、可撓性容器内の溶解液の一部は薬
剤容器内の薬剤と混合される。そして、混合液が可撓性
容器内に連通針を介して戻され、点滴溶液として可撓性
容器から排出される。この場合、連通針は少なくとも薬
剤容器のゴム栓に刺通されるが、ゴム栓の被刺通面は保
護膜で覆われ、化学滅菌が安全に行われる。そして、連
通針がゴム栓を刺通する際に、先ず連通針は保護膜を刺
通する。このとき、保護膜の破砕部は展性により被刺通
面に向かって延びる。この場合、延びた部分がゴム栓の
被刺通面に到達すると、連通針の移動によってゴム栓内
に埋没する。埋没した金属部分は連通針の移動及びゴム
栓の弾性圧迫によってゴム栓内で引きちぎられてフラグ
メントとして薬剤容器内に出るおそれがある。いわゆる
保護膜のコアリング現象が生じるおそれがある。しか
し、本発明においては、保護膜は被刺通面と0.7mm
以上、特に、刺通される連通針の外径の1/2以上であ
れば、保護膜の延びた部分が被刺通面に到達することが
困難となり、保護膜がゴム栓内に埋没してコアリング等
を起こすことがない。従って、薬剤容器は、連結口内で
の安全な滅菌がなされ、連通針の刺通に際して汚染物等
が薬剤容器内に混入するおそれがない。The inside of the medicine container is communicated with the inside of the flexible container by a communication needle, and a part of the solution in the flexible container is mixed with the medicine in the medicine container. Then, the mixed solution is returned into the flexible container via the communication needle, and is discharged from the flexible container as an infusion solution. In this case, the communication needle is pierced at least through the rubber stopper of the medicine container, but the pierced surface of the rubber stopper is covered with the protective film, and the chemical sterilization is performed safely. Then, when the communication needle pierces the rubber stopper, first, the communication needle pierces the protective film. At this time, the crushed portion of the protective film extends toward the pierced surface by malleability. In this case, when the extended portion reaches the pierced surface of the rubber stopper, it is embedded in the rubber stopper due to the movement of the communication needle. The buried metal part may be torn in the rubber stopper by the movement of the communication needle and the elastic compression of the rubber stopper, and may be fragmented into the medicine container. A so-called coring phenomenon of the protective film may occur. However, in the present invention, the protective film is 0.7 mm
In particular, if the outer diameter of the communicating needle to be pierced is equal to or more than の, it is difficult for the extended portion of the protective film to reach the pierced surface, and the protective film is buried in the rubber stopper. No coring occurs. Therefore, the drug container is safely sterilized in the connection port, and there is no possibility that contaminants or the like will be mixed into the drug container when the communication needle is pierced.
【0008】[0008]
【実施例】以下、本発明に係る薬剤容器の好ましい実施
例を添付図面を参照しながら詳述する。図1及び図2は
本発明に係る薬剤容器の第一実施例の正断面図である。
図3及び図4は第一実施例の使用に際しての正断面図で
ある。DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Preferred embodiments of a medicine container according to the present invention will be described below in detail with reference to the accompanying drawings. 1 and 2 are front sectional views of a first embodiment of a medicine container according to the present invention.
3 and 4 are front sectional views when the first embodiment is used.
【0009】本発明に係る第一実施例の薬剤バイアル
(薬剤容器)5は図1〜図4に示す如く、薬剤6が収納
され、開口部51がゴム栓7で密封され、外部から内部
に通ずる連通路を確保するために連通針をゴム栓7に刺
通して用いる容器である。バイアル5はゴム栓7の被刺
通面71が連通針で刺通可能な保護膜81で覆われてお
り、保護膜81の表面が滅菌処理されている。そして、
バイアル5はゴム栓7の被刺通面71と保護膜81とが
連通針の刺通時点で0.7mm以上離間している。バイ
アル5の保護膜81は被刺通面71から浮き上がらせて
配され、保護膜81はステンレスからなり、被刺通面7
1を覆う部分を除いて肉厚に形成され、且つゴム栓7を
開口部51に固定するためのカシメキャップ8の一部で
ある。また、バイアル5における保護膜81の表面の滅
菌処理が過酸化水素水による化学滅菌処理である。そし
て、図2に示す如く、連通針9を具備した可撓性容器1
0に連結されており、ゴム栓7の被刺通面71と保護膜
81とが連通針13の外径Lの1/2以上離間してい
る。As shown in FIGS. 1 to 4, a medicine vial (medicine container) 5 according to the first embodiment of the present invention contains a medicine 6, an opening 51 is sealed with a rubber stopper 7, and the medicine is introduced from outside to inside. This is a container used to pierce the rubber stopper 7 with a communication needle to secure a communication passage. In the vial 5, the pierced surface 71 of the rubber stopper 7 is covered with a protective film 81 that can be pierced with a communication needle, and the surface of the protective film 81 is sterilized. And
In the vial 5, the surface 71 to be pierced of the rubber stopper 7 and the protective film 81 are separated from each other by 0.7 mm or more when the communicating needle is pierced. The protective film 81 of the vial 5 is disposed so as to rise from the pierced surface 71, and the protective film 81 is made of stainless steel.
1 is a part of a caulking cap 8 formed to be thick except for a portion covering 1 and fixing the rubber plug 7 to the opening 51. The sterilization of the surface of the protective film 81 in the vial 5 is a chemical sterilization with a hydrogen peroxide solution. Then, as shown in FIG. 2, the flexible container 1 having the communication needle 9 is provided.
0, and the piercing surface 71 of the rubber plug 7 and the protective film 81 are separated from each other by 1 / or more of the outer diameter L of the communication needle 13.
【0010】本実施例に係るバイアル5を更に詳しく説
明すると、図1に示す如くバイアル5内に凍結乾燥され
た薬剤6が無菌充填されており、バイアル5の開口部5
1はゴム栓7で密封されている。ゴム栓7は被刺通面7
1を有し、被刺通面71には金属製或いは樹脂製の連通
針が刺通可能になっている。また、ゴム栓7にはカシメ
キャップ8が取付けられ、カシメキャップ8はカシメて
開口部51のフランジ部52に固着されている。カシメ
キャップ8はステンレス製であり、打ち抜き延伸等によ
り連通針が刺通される中央面は薄肉の保護膜81となっ
ている。即ち、保護膜81はゴム栓7の被刺通面71を
覆っており、被刺通面71から浮き上がり形成されてい
る。そして、保護膜81の厚みは5μm〜100μmに
形成されているが、その周囲、特に保護膜81の浮き上
がりを支える肩部82は容易に変形しない肉厚部となっ
ている。The vial 5 according to this embodiment will be described in more detail. As shown in FIG. 1, the vial 5 is filled with a freeze-dried drug 6 aseptically, and the vial 5 has an opening 5.
Reference numeral 1 is sealed with a rubber stopper 7. Rubber stopper 7 is pierced surface 7
1, a communication needle made of metal or resin can penetrate the pierced surface 71. A caulking cap 8 is attached to the rubber stopper 7, and the caulking cap 8 is caulked and fixed to the flange 52 of the opening 51. The caulking cap 8 is made of stainless steel and has a thin protective film 81 on the central surface through which the communication needle is pierced by punching and stretching. That is, the protective film 81 covers the pierced surface 71 of the rubber plug 7 and is formed so as to rise from the punctured surface 71. The protective film 81 is formed to have a thickness of 5 μm to 100 μm. The periphery of the protective film 81, particularly the shoulder portion 82 that supports the floating of the protective film 81, is a thick portion that is not easily deformed.
【0011】ゴム栓7の被刺通面71と保護膜81との
間Sは、連通針13の外径Lの1/2以上であることが
望ましい。通常、連通針13は溶解液11及び混合液が
バイアル5内と可撓性容器10内との間をポンピング等
により往復するため、金属製では外径が1.4mm、樹
脂製では外径が3.0mm以上要求される。このため、
被刺通面71と保護膜81との間Sは0.7mm以上、
特に1.5mm以上、更には2.0mm以上離間してい
ることが望ましい。連通針の外径の1/2を下回ると、
保護膜81が破壊された時、その破壊部分が被刺通面7
1まで到達し、連通針によりゴム栓7内に巻き込まれる
おそれがある。また、離間Sが2.0mm以上であれ
ば、連通針に複数通路を設けることが容易にできるた
め、上記溶液の流通をスムースにできる等の利点があ
る。It is desirable that the distance S between the piercing surface 71 of the rubber plug 7 and the protective film 81 is not less than の of the outer diameter L of the communication needle 13. Usually, the communication needle 13 has an outer diameter of 1.4 mm for metal and an outer diameter of resin because the dissolving solution 11 and the mixed solution reciprocate between the vial 5 and the flexible container 10 by pumping or the like. 3.0 mm or more is required. For this reason,
S between the piercing surface 71 and the protective film 81 is 0.7 mm or more,
In particular, it is desirable that they are separated by 1.5 mm or more, more preferably 2.0 mm or more. If it is less than 1/2 of the outer diameter of the communication needle,
When the protective film 81 is broken, the broken portion is
1 and may be caught in the rubber stopper 7 by the communication needle. Further, if the separation S is 2.0 mm or more, it is easy to provide a plurality of passages in the communication needle, so that there is an advantage that the flow of the solution can be smoothed.
【0012】また図2に示す如く、バイアル5は予め可
撓性容器10と連結されていても良い。即ち、可撓性容
器10内には溶解液11が収納され、連結口12が設け
られている。連結口12内には連通針13が予め無菌的
に配されている。可撓性容器10は、直鎖状低密度ポリ
エチレンをインフレーション成形した筒状シートを所定
の長さに裁断して、裁断両端部を熱溶着により固着シー
ルして形成されている。図示しない端部には排出口が取
り付けられ、端部10Aには連結口12が取付られてい
る。連結口12は連結口部材14と連通針13と収納材
15とからなり、連結口部材14は筒体で、樹脂製の連
結針13及び収納材15が挿入収容され、連通針13は
先端に刺通部13Aが形成され基端に取付用フランジ1
3Bが形成されている。取付用フランジ13Bは連結口
部材14に熱溶着により液密に取付られ、連通針13は
収納材15に収納されている。収納材15は可撓性キャ
ップからなり、先端に接続部材16が取り付けられてい
る。As shown in FIG. 2, the vial 5 may be connected to the flexible container 10 in advance. That is, the solution 11 is stored in the flexible container 10, and the connection port 12 is provided. A communication needle 13 is aseptically disposed in the connection port 12 in advance. The flexible container 10 is formed by cutting a tubular sheet obtained by inflation molding of a linear low-density polyethylene into a predetermined length, and fixing and sealing both ends of the cut by heat welding. A discharge port is attached to the end (not shown), and a connection port 12 is attached to the end 10A. The connection port 12 includes a connection port member 14, a communication needle 13, and a storage material 15. The connection port member 14 is a cylindrical body, into which the resin connection needle 13 and the storage material 15 are inserted and housed. A piercing portion 13A is formed and a mounting flange 1 is provided at a base end.
3B is formed. The mounting flange 13 </ b> B is liquid-tightly mounted to the connection port member 14 by heat welding, and the communication needle 13 is stored in the storage material 15. The storage member 15 is formed of a flexible cap, and a connection member 16 is attached to a distal end.
【0013】接続部材16は連結口部材14に設けられ
るストッパー17に支持され、またカプセル18の接続
口18Aに嵌着されている。樹脂製の保持カプセル18
内にバイアル5が収納され、保持カプセル18は天面に
樹脂製蓋体19が取付られている。蓋体19は図示しな
い協合部を介して保持カプセル18に接合され、その協
合部の破壊によりカプセル18内から使用後のバイアル
5を抜き出すことができるようになっている。従って、
使用後、ガラス製のバイアルなどの廃棄処理が容易にな
っている。カプセル18内のバイアル5のゴム栓7及び
カシメキャップ8の外周縁にはゴム製の弾性パッキン2
0が液密に取付られ、弾性パッキン20の一部20Aは
カプセル18の接続口18Aの内周壁の一部を液密に覆
っている。また、接続部材16と接続口18Aの接続の
際に、接続口18A内が過酸化水素水等の化学滅菌がな
されており、接続後は、カシメキャップ8の保護膜81
の表面が滅菌維持されている。カプセル18と連結口1
2との間に案内用の樹脂製支持筒21が配せられる。支
持筒21は、ストッパー17を取り外した時にカプセル
18が可撓性容器10に正確に移動するように案内して
いる。The connection member 16 is supported by a stopper 17 provided on the connection port member 14 and is fitted to a connection port 18A of the capsule 18. Resin capsule 18 made of resin
The vial 5 is housed therein, and the holding capsule 18 has a resin lid 19 attached to the top surface. The lid 19 is joined to the holding capsule 18 via a cooperating portion (not shown), and the used vial 5 can be extracted from the capsule 18 by breaking the cooperating portion. Therefore,
After use, disposal of glass vials and the like is easy. The rubber stopper 7 of the vial 5 and the outer peripheral edge of the caulking cap 8 in the capsule 18 are provided with a rubber elastic packing 2.
0 is mounted in a liquid-tight manner, and a part 20A of the elastic packing 20 liquid-tightly covers a part of the inner peripheral wall of the connection port 18A of the capsule 18. When connecting the connection member 16 and the connection port 18A, the inside of the connection port 18A is chemically sterilized with a hydrogen peroxide solution or the like, and after the connection, the protection film 81 of the caulking cap 8 is connected.
The surface is kept sterile. Capsule 18 and connection 1
2, a resin support cylinder 21 for guiding is provided. The support cylinder 21 guides the capsule 18 to move accurately to the flexible container 10 when the stopper 17 is removed.
【0014】次に、第一実施例の薬剤容器であるバイア
ルの使用について説明する。図2に示す状態で、ストッ
パー17を取り外し、カプセル18を支持筒21内に押
し込む。これにより、カプセル18の接続口18A及び
接続部材16が連結口部材14の開口内に押し込まれる
(図3)。押し込まれることにより、連結針13は収納
材15の先端部及びゴム栓7の被刺通面71を刺通し、
可撓性容器10とバイアル5とが連通し、ポンピングに
より可撓性容器10内の溶解液11と薬剤6とを混合
し、可撓性容器10内に戻して点滴を開始する。この場
合、図4に示す如く、保護膜81の破砕部は展性により
被刺通面71に向かって延びる。しかし、保護膜81を
支持している肩部82は肉厚になっており、連通針13
の刺通衝撃に対して耐変形性を示す。このため、連通針
13の刺通の瞬間においても保護膜81と被刺通面71
とは離間し、保護膜81の延びた部分がゴム栓7の被刺
通面71に到達することはなく、連通針13の移動によ
ってゴム栓7内に埋没するおそれがない。従って、保護
膜81の一部がフラグメントとしてバイアル5内に飛散
することはない。Next, the use of the vial as the medicine container of the first embodiment will be described. In the state shown in FIG. 2, the stopper 17 is removed, and the capsule 18 is pushed into the support cylinder 21. Thereby, the connection port 18A and the connection member 16 of the capsule 18 are pushed into the opening of the connection port member 14 (FIG. 3). By being pushed in, the connecting needle 13 pierces the distal end portion of the storage material 15 and the pierced surface 71 of the rubber plug 7,
The flexible container 10 and the vial 5 communicate with each other, and the solution 11 and the medicine 6 in the flexible container 10 are mixed by pumping, and the mixture is returned into the flexible container 10 to start infusion. In this case, as shown in FIG. 4, the crushed portion of the protective film 81 extends toward the pierced surface 71 by malleability. However, the shoulder portion 82 supporting the protective film 81 is thick, and the communication needle 13
Deformation resistance to piercing impact. Therefore, even at the moment when the communication needle 13 is pierced, the protective film 81 and the pierced surface 71
The extended portion of the protective film 81 does not reach the pierced surface 71 of the rubber plug 7, and there is no risk of being buried in the rubber plug 7 by the movement of the communication needle 13. Therefore, a part of the protective film 81 does not scatter in the vial 5 as a fragment.
【0015】次に、本発明に係る第二実施例の薬剤容器
を添付図面の図5に従って説明する。図5は第二実施例
のバイアルの正断面図である。図5に示す第二実施例の
バイアル31が第一実施例のバイアル5とほぼ同一の構
造を有しており、異なる点は、ゴム栓32とカシメキャ
ップ33にある。ゴム栓32の中央部には穴34が形成
され、穴34の底面35は薄肉化されて連通針の刺通が
可能な被刺通面となっている。また、ゴム栓32にはア
ルミ製のカシメキャップ33が取付られ、穴34の開口
面にはカシメキャップ33の薄肉化された肉薄部分36
が形成されている。従って、被刺通面である穴34の底
面35と保護膜部分である肉薄部分36は離間された状
態にあり、かかる離間距離は穴34の深さによって決定
される。本実施例では深さが0.7mm以上で、詳しく
は5.0mmに形成されている。このような構成にあっ
ても、連通針がゴム栓32に刺通されたとき、第一実施
例のバイアル5と同様にコアリング等が生じない。Next, a medicine container according to a second embodiment of the present invention will be described with reference to FIG. 5 of the accompanying drawings. FIG. 5 is a front sectional view of the vial of the second embodiment. The vial 31 of the second embodiment shown in FIG. 5 has substantially the same structure as the vial 5 of the first embodiment, but differs in a rubber stopper 32 and a caulking cap 33. A hole 34 is formed in the center of the rubber plug 32, and the bottom surface 35 of the hole 34 is thinned to form a pierced surface through which a communication needle can be pierced. An aluminum caulking cap 33 is attached to the rubber stopper 32, and a thinned thin portion 36 of the caulking cap 33 is provided on the opening surface of the hole 34.
Are formed. Therefore, the bottom surface 35 of the hole 34, which is the piercing surface, and the thin portion 36, which is the protective film portion, are separated from each other, and the distance is determined by the depth of the hole 34. In the present embodiment, the depth is 0.7 mm or more, specifically, 5.0 mm. Even in such a configuration, when the communication needle is pierced through the rubber stopper 32, coring or the like does not occur as in the vial 5 of the first embodiment.
【0016】上記実施例において、収納材15と弾性パ
ッキン20との無菌接続に過酸化水素を用いたが、本発
明において、過酸化水素以外の殺菌効果のある化学物質
を用いても良い。上記実施例において、ゴム製のゴム栓
7及び弾性パッキン20を用いたが、本発明では、接続
面が液密にできる弾性部材である限り、熱可塑性エラス
トマーなどでも良い。上記実施例において、可撓性容器
10に溶解液11を充填した。本発明では溶解液、又は
希釈液として、通常使用されている輸液などが充填され
ていても良い。上記実施例において、バイアル5に凍結
乾燥物を充填したが、本発明では場合によって薬液を充
填しておいても良い。また、バイアル5はガラス製であ
るが、本発明において樹脂容器を用いても良い。上記実
施例において、カシメキャップをステンレス製及びアル
ミニウム製としたが、ゴム栓を十分に保護するものであ
れば、金属膜に限ることはなく、耐変形性のプラスチッ
ク材を用いても良い。In the above embodiment, hydrogen peroxide is used for the aseptic connection between the storage material 15 and the elastic packing 20, but in the present invention, a chemical substance having a sterilizing effect other than hydrogen peroxide may be used. In the above embodiment, the rubber stopper 7 and the elastic packing 20 are used. However, in the present invention, a thermoplastic elastomer or the like may be used as long as the connecting surface is an elastic member that can be made liquid-tight. In the above example, the solution 11 was filled in the flexible container 10. In the present invention, a commonly used infusion solution or the like may be filled as a solution or a diluting solution. In the above embodiment, the vial 5 is filled with the lyophilized substance. However, in the present invention, the drug solution may be filled in some cases. Although the vial 5 is made of glass, a resin container may be used in the present invention. In the above embodiment, the caulking cap is made of stainless steel or aluminum. However, as long as it can sufficiently protect the rubber stopper, it is not limited to a metal film, and a plastic material having deformation resistance may be used.
【0017】[0017]
【発明の効果】以上説明したように本発明に係る薬剤容
器では、ゴム栓の被刺通面と上記保護膜とが連通針の刺
通時点で0.7mm以上離間しているので、可撓性容器
を無菌的に連結する場合、連結直前にゴム栓の表面を安
全且つ確実に滅菌若しくは殺菌することができ、また連
通針の刺通時に薬剤等の汚染が生じない。As described above, in the medicine container according to the present invention, since the piercing surface of the rubber stopper and the protective film are separated from each other by 0.7 mm or more at the time of piercing of the communication needle, the medicine container is flexible. When the sex containers are connected aseptically, the surface of the rubber stopper can be safely and reliably sterilized or sterilized immediately before the connection, and no contamination of medicine or the like occurs when the communication needle is pierced.
【図1】本発明に係る薬剤容器の第一実施例の正断面図
である。FIG. 1 is a front sectional view of a first embodiment of a medicine container according to the present invention.
【図2】第一実施例に予め可撓性容器及び連通針を取り
付けた断面図である。FIG. 2 is a cross-sectional view in which a flexible container and a communication needle are previously attached to the first embodiment.
【図3】第一実施例の薬剤容器と可撓性容器を連通させ
た状態を示す断面図である。FIG. 3 is a cross-sectional view showing a state in which the medicine container according to the first embodiment and the flexible container are in communication with each other.
【図4】図3の要部拡大断面図である。FIG. 4 is an enlarged sectional view of a main part of FIG.
【図5】第二実施例の薬剤容器の正断面図である。FIG. 5 is a front sectional view of the medicine container of the second embodiment.
5、31 薬剤バイアル 6 薬剤 7 ゴム栓 8 カシメキャップ 10 可撓性容器 11 溶解液 5, 31 drug vial 6 drug 7 rubber stopper 8 caulking cap 10 flexible container 11 solution
Claims (6)
部はゴム栓で密封され、上記容器の外部から容器内部に
通ずる連通路を確保するために連通針をゴム栓に刺通し
て用いる薬剤容器であって、少なくとも上記ゴム栓の被
刺通面が上記連通針で刺通可能な保護膜で覆われてお
り、上記保護膜の表面が滅菌処理されている薬剤容器に
おいて、 上記ゴム栓の被刺通面と上記保護膜とが連通針の刺通時
点で0.7mm以上離間していることを特徴とする薬剤
容器。1. A drug which is contained in a container, the opening of which is sealed with a rubber stopper, and which is used by piercing a rubber stopper with a communication needle to secure a communication path from the outside of the container to the inside of the container. A container, wherein at least the surface to be pierced by the rubber stopper is covered with a protective film that can be pierced by the communication needle, and the surface of the protective film is sterilized. A drug container, wherein the surface to be pierced and the protective film are separated by 0.7 mm or more when the communication needle is pierced.
せて配されている請求項1記載の薬剤容器。2. The drug container according to claim 1, wherein the protective film is arranged so as to float above the surface to be penetrated.
穴の底面を上記被刺通面とする請求項1記載の薬剤容
器。3. The drug container according to claim 1, wherein a hole is formed on the surface of the rubber stopper, and the bottom surface of the hole is the surface to be penetrated.
ス金属からなり、上記被刺通面を覆う部分を除いて肉厚
に形成され、且つ上記ゴム栓を上記開口部に固定するた
めのカシメキャップの一部である請求項1〜3の何れか
に記載の薬剤容器。4. The protective film is made of aluminum or stainless metal, is formed thick except for a portion covering the surface to be pierced, and is a caulking cap for fixing the rubber stopper to the opening. The drug container according to claim 1, which is a part.
4記載の薬剤容器。5. The drug container according to claim 4, wherein the sterilization treatment is chemical sterilization treatment.
おり、上記ゴム栓の被刺通面と上記保護膜とが上記連通
針の外径Lの1/2以上離間していることを特徴とする
請求項1〜5記載の薬剤容器。6. A flexible container provided with a communicating needle, wherein the pierced surface of the rubber stopper and the protective film are separated from each other by 1/2 or more of the outer diameter L of the communicating needle. The chemical | medical agent container of Claim 1-5 characterized by the above-mentioned.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8122657A JP2808268B2 (en) | 1996-04-19 | 1996-04-19 | Drug container |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8122657A JP2808268B2 (en) | 1996-04-19 | 1996-04-19 | Drug container |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH09285522A true JPH09285522A (en) | 1997-11-04 |
JP2808268B2 JP2808268B2 (en) | 1998-10-08 |
Family
ID=14841409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8122657A Expired - Fee Related JP2808268B2 (en) | 1996-04-19 | 1996-04-19 | Drug container |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2808268B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001278320A (en) * | 2000-03-31 | 2001-10-10 | Otsuka Pharmaceut Factory Inc | Cap and its manufacturing method, and drug container using the cap |
JP2004081684A (en) * | 2002-08-28 | 2004-03-18 | Ishida Press Kogyo Kk | Cap for medicine vial |
JP2011078810A (en) * | 2010-12-06 | 2011-04-21 | Naigai Kasei Kk | Infusion cap |
-
1996
- 1996-04-19 JP JP8122657A patent/JP2808268B2/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001278320A (en) * | 2000-03-31 | 2001-10-10 | Otsuka Pharmaceut Factory Inc | Cap and its manufacturing method, and drug container using the cap |
JP2004081684A (en) * | 2002-08-28 | 2004-03-18 | Ishida Press Kogyo Kk | Cap for medicine vial |
JP2011078810A (en) * | 2010-12-06 | 2011-04-21 | Naigai Kasei Kk | Infusion cap |
Also Published As
Publication number | Publication date |
---|---|
JP2808268B2 (en) | 1998-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5743312A (en) | Component mixing apparatus and system including a movable cannula | |
ES2740107T3 (en) | Medical device for access to the road with pressure compensation and closed drug transfer system | |
US6398031B1 (en) | Vial for packaging a liquid for medical use | |
NZ203183A (en) | Container with frangible seal at opening | |
US4253459A (en) | Additive transfer unit with stabilized sealing means | |
PL209749B1 (en) | Medicament vial having a heat-sealable cap, and apparatus and method for filling the vial | |
US9005181B2 (en) | Sterile openable access port and containers including the same | |
US10123939B2 (en) | Hermetic closing plug for a sealed sterile vial containing medical or nutritional active substances, suitable for the sterile connection to a container of liquid diluent solution, and sterile connection system using said closing plug | |
JP2808268B2 (en) | Drug container | |
US20130269827A1 (en) | Two compartment syringe accessible package and method of using and making the same | |
JPH09294800A (en) | Medicine container | |
US20210077732A1 (en) | Ready-to-use cryoresistant injection device | |
JPH09299447A (en) | Infusion container with medicine container | |
JPH09299446A (en) | Medicine container and infusion container provided with it | |
JPH09327500A (en) | Medicine vessel and transfusion vessel equipped with the same | |
JP2000107255A (en) | Drug-mixing transfusion container | |
JPH0788151A (en) | Drug-containing vessel | |
JPH07479A (en) | Transfusion bottle | |
JPH07313572A (en) | Infusion vessel | |
JPH09262271A (en) | Medical container and its manufacture | |
JPH1128243A (en) | Medical container | |
JPH09248328A (en) | Container for medical treatment and its production | |
EP1600139A1 (en) | Airtight container for storing a liquid, and in particular a medicament, and aseptic process for filing said container | |
JPH11379A (en) | Medical container | |
JP2000116749A (en) | Transfuse container |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |